[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 44, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1179148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 50, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 691583, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 43, "title": "General Counsel & Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 577338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 48, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 41, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 72.84, "open": 71.25, "dayLow": 71.25, "dayHigh": 79.06, "regularMarketPreviousClose": 72.84, "regularMarketOpen": 71.25, "regularMarketDayLow": 71.25, "regularMarketDayHigh": 79.06, "beta": 2.687, "forwardPE": -6.5248346, "volume": 499460, "regularMarketVolume": 499460, "averageVolume": 334667, "averageVolume10days": 501090, "averageDailyVolume10Day": 501090, "bid": 76.01, "ask": 77.17, "bidSize": 100, "askSize": 100, "marketCap": 1426164352, "fiftyTwoWeekLow": 19.61, "fiftyTwoWeekHigh": 86.93, "priceToSalesTrailing12Months": 888.5759, "fiftyDayAverage": 73.31, "twoHundredDayAverage": 57.16215, "currency": "USD", "enterpriseValue": 1070790720, "floatShares": 13996411, "sharesOutstanding": 18637800, "sharesShort": 1465295, "sharesShortPriorMonth": 1724599, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.078600004, "heldPercentInsiders": 0.00245, "heldPercentInstitutions": 1.04013, "shortRatio": 3.97, "shortPercentOfFloat": 0.0787, "impliedSharesOutstanding": 18637800, "bookValue": 21.515, "priceToBook": 3.5565884, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -151018000, "trailingEps": -9.17, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 667.159, "enterpriseToEbitda": -6.545, "52WeekChange": 2.3649957, "SandP52WeekChange": 0.2421279, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PRAX", "underlyingSymbol": "PRAX", "shortName": "Praxis Precision Medicines, Inc", "longName": "Praxis Precision Medicines, Inc.", "firstTradeDateEpochUtc": 1602855000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d9e1bd55-646b-3409-879b-a7984b5b3499", "messageBoardId": "finmb_409236524", "gmtOffSetMilliseconds": -18000000, "currentPrice": 76.52, "targetHighPrice": 305.0, "targetLowPrice": 57.0, "targetMeanPrice": 162.6, "targetMedianPrice": 150.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 357032000, "totalCashPerShare": 19.156, "ebitda": -163592992, "totalDebt": 1660000, "quickRatio": 10.865, "currentRatio": 10.957, "totalRevenue": 1605000, "debtToEquity": 0.434, "revenuePerShare": 0.106, "returnOnAssets": -0.39202, "returnOnEquity": -0.64342004, "freeCashflow": -48460376, "operatingCashflow": -99496000, "revenueGrowth": -0.355, "operatingMargins": -188.19536, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-21"}]